Implementation of a maternity hospital rotational thromboelastometry (ROTEM®) guided transfusion strategy: a quality improvement study*

IF 0.8 Q3 ANESTHESIOLOGY
H. Tawfik, L. Pentony, R. M. O'Donovan, S. R. Mir, M. Tahir, T. Drew
{"title":"Implementation of a maternity hospital rotational thromboelastometry (ROTEM®) guided transfusion strategy: a quality improvement study*","authors":"H. Tawfik,&nbsp;L. Pentony,&nbsp;R. M. O'Donovan,&nbsp;S. R. Mir,&nbsp;M. Tahir,&nbsp;T. Drew","doi":"10.1002/anr3.70028","DOIUrl":null,"url":null,"abstract":"<p>A rotational thromboelastometry (ROTEM<sup>®</sup>) guided transfusion strategy for obstetrics was implemented at our institution in September 2022. The aim of the strategy was to facilitate timely, targeted administration of coagulation products based on viscoelastic haemostatic testing, thereby reducing unnecessary transfusions. To improve compliance with the ROTEM<sup>®</sup> strategy, an electronic decision tool was developed and integrated into a smartphone application, supported by departmental education and training. We subsequently analysed data on 944 women who experienced postpartum haemorrhage ≥ 1500 ml over a 5-year period, comparing 1 year of data after the formal introduction of the ROTEM<sup>®</sup>-guided transfusion strategy (post-ROTEM<sup>®</sup>) with the previous 4 years, when a conventional transfusion strategy was in place based on standard laboratory tests (pre-ROTEM<sup>®</sup>). Following implementation, the annual use of fibrinogen concentrate, Octaplas<sup>®</sup> (Octapharma Pharmazeutika GmbH, Vienna, Austria) and platelets to treat PPH ≥ 1500 ml decreased by 46%, 72% and 79%, respectively, yielding a cost saving of €51,738. Compliance with evidence-based fibrinogen transfusion triggers improved significantly (84% vs. 23%) and empirical product use was eliminated. There was no statistically significant difference in the proportion of women who progressed to severe haemorrhage (≥ 2000 ml) between groups: 97/238 (40%) in the post-ROTEM<sup>®</sup> group vs. 312/706 (44%) in the pre-ROTEM group (p = 0.35). This quality improvement initiative demonstrated that embedding a ROTEM<sup>®</sup>-guided transfusion strategy into clinical workflows, supported by a decision tool and staff training, can enhance adherence to evidence-based practice, reduce unnecessary coagulation product use and generate substantial cost savings, without adversely affecting clinical outcomes. These findings may inform institutions seeking to optimise transfusion strategies in obstetric haemorrhage through structured implementation approaches.</p>","PeriodicalId":72186,"journal":{"name":"Anaesthesia reports","volume":"13 2","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/epdf/10.1002/anr3.70028","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anaesthesia reports","FirstCategoryId":"1085","ListUrlMain":"https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1002/anr3.70028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

A rotational thromboelastometry (ROTEM®) guided transfusion strategy for obstetrics was implemented at our institution in September 2022. The aim of the strategy was to facilitate timely, targeted administration of coagulation products based on viscoelastic haemostatic testing, thereby reducing unnecessary transfusions. To improve compliance with the ROTEM® strategy, an electronic decision tool was developed and integrated into a smartphone application, supported by departmental education and training. We subsequently analysed data on 944 women who experienced postpartum haemorrhage ≥ 1500 ml over a 5-year period, comparing 1 year of data after the formal introduction of the ROTEM®-guided transfusion strategy (post-ROTEM®) with the previous 4 years, when a conventional transfusion strategy was in place based on standard laboratory tests (pre-ROTEM®). Following implementation, the annual use of fibrinogen concentrate, Octaplas® (Octapharma Pharmazeutika GmbH, Vienna, Austria) and platelets to treat PPH ≥ 1500 ml decreased by 46%, 72% and 79%, respectively, yielding a cost saving of €51,738. Compliance with evidence-based fibrinogen transfusion triggers improved significantly (84% vs. 23%) and empirical product use was eliminated. There was no statistically significant difference in the proportion of women who progressed to severe haemorrhage (≥ 2000 ml) between groups: 97/238 (40%) in the post-ROTEM® group vs. 312/706 (44%) in the pre-ROTEM group (p = 0.35). This quality improvement initiative demonstrated that embedding a ROTEM®-guided transfusion strategy into clinical workflows, supported by a decision tool and staff training, can enhance adherence to evidence-based practice, reduce unnecessary coagulation product use and generate substantial cost savings, without adversely affecting clinical outcomes. These findings may inform institutions seeking to optimise transfusion strategies in obstetric haemorrhage through structured implementation approaches.

Abstract Image

Abstract Image

Abstract Image

Abstract Image

妇产医院旋转血栓弹性测量(ROTEM®)指导输血策略的实施:一项质量改进研究*
旋转血栓弹性测量(ROTEM®)指导的产科输血策略于2022年9月在我院实施。该策略的目的是促进基于粘弹性止血试验的凝血产品的及时、有针对性的给药,从而减少不必要的输血。为了提高对ROTEM®战略的遵从性,在部门教育和培训的支持下,开发了一个电子决策工具并将其集成到智能手机应用程序中。随后,我们分析了944名5年内产后出血≥1500ml的妇女的数据,将正式引入ROTEM®指导的输血策略(后ROTEM®)后1年的数据与之前4年的数据进行比较,当时采用了基于标准实验室测试的传统输血策略(前ROTEM®)。实施后,每年使用纤维蛋白原浓缩物、Octaplas®(Octapharma Pharmazeutika GmbH,维也纳,奥地利)和血小板治疗PPH≥1500 ml分别减少46%、72%和79%,节省成本51,738欧元。循证纤维蛋白原输血触发的依从性显著提高(84%对23%),并消除了经验性产品的使用。两组之间进展为严重出血(≥2000 ml)的女性比例无统计学差异:rotem®后组为97/238(40%),而rotem®前组为312/706 (44%)(p = 0.35)。这一质量改进举措表明,在决策工具和员工培训的支持下,将ROTEM®指导的输血策略纳入临床工作流程,可以增强对循证实践的依从性,减少不必要的凝血产品使用,并节省大量成本,而不会对临床结果产生不利影响。这些发现可以为寻求通过结构化的实施方法优化产科出血输血策略的机构提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信